General
Preferred name
vincamine
Synonyms
Angiopac ()
Devincan ()
Equipur ()
Novicet ()
Oxybral ()
Perval ()
Angiopac, Devincan, Equipur, Minorin, Novicet, Oxybral, Perval, Sostenil, Tripervan ()
Pervincamine ()
Vincagil ()
Oxygeron ()
Arteriovinca ()
Vraap ()
NSC-91998 ()
Cetal retard ()
Vincafor ()
Cetal ()
Vincimax ()
P&D ID
PD012069
CAS
1617-90-9
Tags
natural product
drug
available
Drug indication
Cerebrovascular disease
Drug Status
experimental
approved
withdrawn
Max Phase
Phase 4
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Cell lines
2
Organisms
0
Compound Sets
17
Cayman Chemical Bioactives
ChEMBL Approved Drugs
ChEMBL Drugs
Drug Repurposing Hub
DrugBank
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
Guide to Pharmacology
MedChem Express Bioactive Compound Library
NPC Screening Collection
Prestwick Chemical Library
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
Withdrawn 2.0
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
29
Properties
(calculated by RDKit )
Molecular Weight
354.19
Hydrogen Bond Acceptors
5
Hydrogen Bond Donors
1
Rotatable Bonds
2
Ring Count
5
Aromatic Ring Count
2
cLogP
2.95
TPSA
54.7
Fraction CSP3
0.57
Chiral centers
3.0
Largest ring
6.0
QED
0.84
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Target
CHRM1, CHRM2, CHRM3, CHRM4
Free Fatty Acid Receptor
MOA
Adrenergic Receptor antagonist
ATC
C04AX07
Toxicity type
hematological
Pathway
GPCR/G protein
Source data
